Audrey French, MD
Basic profileAudrey French is an Infectious Disease physician affiliated with Rush University Medical Center. OpenAlex indexes 263 publications with 6,638 citations (h-index 41).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202511 payments$2,002
- Gilead Sciences, Inc.Program year20252 payments$140
- Janssen Pharmaceuticals, IncProgram year20221 payment$23
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
51.6%Protease Inhibitor20.4%Prezcobix52%Symtuza19%Prezista11%Atazanavir Sulfate9%Ritonavir9%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor12.5%Triumeq46%Emtricitabine-Tenofovir Disop22%Descovy17%Emtricitabine16%Part D<11 patients+ 5 more classes in this area
Cardiovascular
16.3%Statin5.3%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor4.4%Enalapril Maleate100%Part D<11 patients+ 2 more classes in this area
Respiratory
13.8%beta2-Adrenergic Agonist6.1%Albuterol Sulfate Hfa100%Part D<11 patientsCorticosteroid3.6%Fluticasone Propionate50%Qvar Redihaler50%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 2009–2025 per NIH RePORTER. The latest:
- MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS)
Hektoen Institute for Medical Research
FY2025$3,000,561U01HL146245 - Keeping it LITE 2: Exploring HIV Risk in Vulnerable Youth with Limited Interaction and Digital Health Intervention (LITE-2)
University of Illinois at Chicago
FY2025$1,609,431UH3AI169631 - MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS)
Hektoen Institute for Medical Research
FY2024$2,980,410U01HL146245
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Neelum Aggarwal, MD
Rush University Medical Center
Philip Bonomi, MD
Rush University Medical Center
Ithaar Derweesh, MD
Rush University Medical Center
Steven Flamm, MD
Rush University Medical Center
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”